Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy.

[1]  Deepak L. Bhatt,et al.  Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy. , 2019, Journal of the American College of Cardiology.

[2]  L. Lerman,et al.  Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia , 2019, Biology of Sex Differences.

[3]  A. Weaver,et al.  Electronic Algorithm Is Superior to Hospital Discharge Codes for Diagnoses of Hypertensive Disorders of Pregnancy in Historical Cohorts , 2018, Mayo Clinic proceedings.

[4]  M. Carroll,et al.  Total and High-density Lipoprotein Cholesterol in Adults: United States, 2015-2016. , 2017, NCHS data brief.

[5]  Michael J Barry,et al.  Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement , 2017, JAMA.

[6]  Lisa E. Vaughan,et al.  Preeclampsia and ESRD: The Role of Shared Risk Factors. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[8]  Krishna K. Saha,et al.  A Comparison of Some Approximate Confidence Intervals for a Single Proportion for Clustered Binary Outcome Data , 2016, The international journal of biostatistics.

[9]  W. Rocca,et al.  Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study , 2016, Mayo Clinic proceedings.

[10]  G. Tell,et al.  Placental aging and oxidation damage in a tissue micro-array model: an immunohistochemistry study , 2016, Histochemistry and Cell Biology.

[11]  Marco Zoli,et al.  Aging and Multimorbidity: New Tasks, Priorities, and Frontiers for Integrated Gerontological and Clinical Research. , 2015, Journal of the American Medical Directors Association.

[12]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[13]  K. Klungsøyr,et al.  Validity of pre-eclampsia registration in the medical birth registry of norway for women participating in the norwegian mother and child cohort study, 1999-2010. , 2014, Paediatric and perinatal epidemiology.

[14]  Gustavo Saposnik,et al.  Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2014, Stroke.

[15]  K. Joseph,et al.  Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. , 2013, American journal of obstetrics and gynecology.

[16]  C. Ananth,et al.  Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis , 2013, BMJ.

[17]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[18]  R. Goodman,et al.  Defining and Measuring Chronic Conditions: Imperatives for Research, Policy, Program, and Practice , 2013, Preventing chronic disease.

[19]  Scott M. Brue,et al.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. , 2012, International journal of epidemiology.

[20]  Yili Hong,et al.  Insights on the Robust Variance Estimator under Recurrent‐Events Model , 2011, Biometrics.

[21]  B. Yawn,et al.  American Journal of Epidemiology Practice of Epidemiology Use of a Medical Records Linkage System to Enumerate a Dynamic Population over Time: the Rochester Epidemiology Project , 2022 .

[22]  Rowena J Dolor,et al.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.

[23]  Faha,et al.  Aha Guideline Effectiveness-based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update a Guideline from the American Heart Association Executive Writing Committee Expert Panel Members Cvd Risk Assessment Table 1. Class Iii Interventions (not Useful/effective and May Be Harmfu , 2022 .

[24]  Christopher H. Jackson,et al.  Multi-State Models for Panel Data: The msm Package for R , 2011 .

[25]  B. Cohn,et al.  Preeclampsia and Cardiovascular Disease Death: Prospective Evidence From the Child Health and Development Studies Cohort , 2010, Hypertension.

[26]  Eric Boerwinkle,et al.  Hypertension in pregnancy as a risk factor for cardiovascular disease later in life , 2010, Journal of hypertension.

[27]  Ling Zheng,et al.  Sex-specific trends in midlife coronary heart disease risk and prevalence. , 2009, Archives of internal medicine.

[28]  Joel W. Cohen,et al.  The Medical Expenditure Panel Survey: A National Information Resource to Support Healthcare Cost Research and Inform Policy and Practice , 2009, Medical care.

[29]  W. Callaghan,et al.  Hypertensive Disorders and Severe Obstetric Morbidity in the United States , 2009, Obstetrics and gynecology.

[30]  Anne B Wallis,et al.  Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. , 2008, American journal of hypertension.

[31]  J. Saver,et al.  A midlife stroke surge among women in the United States , 2007, Neurology.

[32]  A. Tabor,et al.  Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. , 2007, American journal of epidemiology.

[33]  J. Shelton,et al.  Population-Based Analysis of Hypertensive Disorders in Pregnancy , 2007, Hypertension in pregnancy.

[34]  Michelle A. Williams,et al.  Monthly variation in preeclampsia prevalence: Washington state, 1987–2001 , 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[35]  S. Kilpatrick,et al.  International Classification of Diseases-9th revision coding for preeclampsia: how accurate is it? , 2004, American journal of obstetrics and gynecology.

[36]  P. Grambsch,et al.  Penalized Survival Models and Frailty , 2003 .

[37]  A. Trumble,et al.  Severe Maternal Morbidity Associated with Hypertensive Disorders in Pregnancy in the United States , 2003, Hypertension in pregnancy.

[38]  P. Grambsch,et al.  Modeling Survival Data: Extending the Cox Model , 2000 .

[39]  J. Cutler,et al.  Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.

[40]  A. Saftlas,et al.  Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. , 1990, American journal of obstetrics and gynecology.

[41]  A. Dreher.  Modeling Survival Data Extending The Cox Model , 2016 .

[42]  M. Budoff,et al.  Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. , 2006, Atherosclerosis.